Comparison of 3 assay systems using a common probe substrate, calcein AM, for studying P-gp using a selected set of compounds

Journal of Biomolecular Screening

Volumn 16, Issue 1, 2011, Pages 112-119

  Szerémy, Péter ^a   Pál, Ákos ^a   Méhn, Dóra ^a   Tóth, Beáta ^a   Fülöp, Ferenc ^b   Krajcsi, Péter ^a   Herédi Szabó, Krisztina ^a  

^a SOLVO BIOTECHNOLOGY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

calcein AM; correlation; in vitro; logP; MDR1

Indexed keywords

CALCEIN; CALCEIN ACETOXYMETHYL ESTER; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; ATPASE ASSAY; CELLULAR DYE EFFLUX ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN INTERACTION; VESICULAR TRANSPORT ASSAY;

BIOLOGICAL ASSAY; BIOLOGICAL TRANSPORT, ACTIVE; FLUORESCEINS; FLUORESCENT DYES; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INHIBITORY CONCENTRATION 50; P-GLYCOPROTEIN; PERMEABILITY; PROTEIN BINDING;

EID: 78951494850     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057110385230     Document Type: Article

References (18)

1. Glavinas H., Mehn D., Jani M., Oosterhuis B., Heredi-Szabo K., Krajcsi P.: Utilization of membrane vesicle preparations to study drug-ABC transporter interactions. Expert Opin Drug Metab Toxicol 2008 ; 4: 721-732.
2. Juliano RL, Ling V.: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976 ; 455: 152-162.
3. Shugarts S., Benet LZ: The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res 2009 ; 26: 2039-2054.
4. Igel S., Drescher S., Murdter T., Hofmann U., Heinkele G., Tegude H.,, et al. Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux. Clin Pharmacokinet 2007 ; 46: 777-785.
5. Aszalos A.: Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1): II. Clinical aspects. Drug Discov Today 2007 ; 12: 838-843.
6. Hollo Z., Homolya L., Davis CW, Sarkadi B.: Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim Biophys Acta 1994 ; 1191: 384-388.
7. Homolya L., Hollo Z., Muller M., Mechetner EB, Sarkadi B.: A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br J Cancer 1996 ; 73: 849-855.
8. Klass CS: The use of the indicator calcein, and its fluorescence, in a rapid, ultramicro titration of serum calcium. Tech Bull Regist Med Technol 1962 ; 32: 77-81.
9. Ambudkar SV, Cardarelli CO, Pashinsky I., Stein WD: Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. J Biol Chem 1997 ; 272: 21160-21166.
10. Polli JW, Wring SA, Humphreys JE, Huang L., Morgan JB, Webster LO,, et al. Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther 2001 ; 299: 620-628.
11. Rautio J., Humphreys JE, Webster LO, Balakrishnan A., Keogh JP, Kunta JR,, et al. In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metab Dispos 2006 ; 34: 786-792.
12. von Richter O., Glavinas H., Krajcsi P., Liehner S., Siewert B., Zech k: A novel screening strategy to identify ABCB1 substrates and inhibitors. Naunyn Schmiedebergs Arch Pharmacol 2009 ; 379: 11-26.
13. Dodic N., Dumaitre B., Daugan A., Pianetti P.: Synthesis and activity against multidrug resistance in Chinese hamster ovary cells of new acridone-4-carboxamides. J Med Chem 1995 ; 38: 2418-2426.
14. Sarkadi B., Price EM, Boucher RC, Germann UA, Scarborough GA: Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 1992 ; 267: 4854-4858.
15. Reid G., Wielinga P., Zelcer N., De Haas M., Van Deemter L., Wijnholds J.,, et al. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol 2003 ; 63: 1094-1103.
16. Taub ME, Podila L., Ely D., Almeida I.: Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Drug Metab Dispos 2005 ; 33: 1679-1687.
17. Ishiwata K., Kawamura K., Yanai K., Hendrikse NH: In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically. J Nucl Med 2007 ; 48: 81-87.
18. von Moltke LL, Granda BW, Grassi JM, Perloff MD, Vishnuvardhan D., Greenblatt DJ: Interaction of triazolam and ketoconazole in P- glycoproteindeficient mice. Drug Metab Dispos 2004 ; 32: 800-804.